Dynavax Technologies Corporation logo DVAX - Dynavax Technologies Corporation

Inactive Ticker DVAX is not actively trading. Quotes and analytics may be stale.
Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 9
HOLD 1
SELL 1
STRONG
SELL
0
| PRICE TARGET: $27.00 DETAILS
HIGH: $32.00
LOW: $20.00
MEDIAN: $29.00
CONSENSUS: $27.00
UPSIDE: 74.19%

About Dynavax Technologies Corporation (https://www.dynavax.com)

Dynavax Technologies Corporation is a biopharmaceutical firm specializing in the development and market introduction of innovative vaccines, primarily operating in the United States. The company's lead product is HEPLISAV-B, a vaccine approved for adults 18 years and older in the U.S. and Europe, which offers protection against all identified subtypes of the hepatitis B virus. Additionally, Dynavax produces and distributes CpG 1018, the specific adjuvant ingredient used in HEPLISAV-B. Dynavax maintains several strategic alliances, including a collaboration agreement with Valneva Scotland Limited, an agreement with Serum Institute of India Pvt. Ltd., and a sublicense agreement with Merck, Sharp & Dohme Corp. The company, incorporated in 1996, was originally named Double Helix Corporation before adopting the name Dynavax Technologies Corporation in September of that year. Its corporate headquarters are situated in Emeryville, California.

Key Executives

NAME TITLE DOB SALARY
Ryan Spencer Chief Executive Officer & Director 1979 $1,484,326 USD
David F. Novack Senior VP & COO 1962 $965,313 USD
Robert Janssen Chief Medical Officer and Senior Vice President of Clinical Development, Medical & Regulatory Affairs 1954 $827,719 USD
John Slebir Senior Vice President & General Counsel 1965 $809,129 USD
Kelly MacDonald Senior Vice President & Chief Financial Officer 1984 $733,501 USD
Dong Yu Senior Vice President of Research
Donn Casale Senior Vice President & Chief Commercial Officer
Eric Frings Vice President, Site Head & MD for Dynavax GmbH
Jeff Coon Senior Vice President & Chief Human Resources Officer 1963
Joseph Metzinger Vice President & Chief Accounting Officer 1984
Meg Smith Senior Vice President of Commercial
Paul Cox Vice President of Investor Relations & Corporate Communications

Company Peers

Peer analysis pending, check back in 1-2 minutes.